Skip to main content

Table 1 Characteristics of evaluated countries.

From: African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults

Characteristic

Burkina Faso*

Senegal*

Niger*

Ghana*

Surveillance design

Prospective

Retrospective

Retrospective

Prospective

Geographic extent

Three districts

Dakar

Niamey

Northern area

Surveillance population

880,000

950,000

550,000

140,000

Rural/Urban

Both

Urban

Urban

Rural

Study years

2002-2005

1970-1979

1981-1996

1998-2003

Microbiological methods

Culture, antigen detection, PCR

Culture

Culture, antigen detection

Culture, antigen detection

Number of confirmed pneumococcal meningitis cases

249

983

934

76

Percent of cases occurring during dry/epidemic season months of Dec-Apr†

75%

49%

63%

69%

Two months with peak number of cases (percent of total)†

Jan-Feb (38%)

Feb-Mar (21%)

Feb-Mar (31%)

Dec-Jan (35%)

Relation of pneumococcal to meningococcal seasonal peak

Similar

2 months in advance

1 month in advance

1 to 2 months in advance

13-valent conjugate vaccine coverage of isolated serotypes

    

Age <5 years

67%

78% (age<2 yrs)

No serotype data

100%

Age 5+ years

77%

94% (age 2+ yrs)

No serotype data

98%

Reference

4,5

9

8

7

  1. * Human immunodeficiency virus prevalence in pregnant women age 15-24 years in capital city: Burkina Faso 2.3% (2002), Ghana 3.9% (2003), Senegal 1.1% (2003). Adult HIV prevalence in Niger was 1.2% (2003). Website: http://www.unicef.org/publications/files/SOWC_2005_(English).pdf, last accessed October 2, 2008.
  2. † In all studies cases per month were estimated from Figures as specific data were not presented.